ANBT
IBB icon

American National Bank & Trust’s iShares Biotechnology ETF IBB Stock Holding History

American National Bank & Trust’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19
Closed -$3.21K – 636
2026
Q1 		$3.21K Hold
19
– – ﹤0.01% 570
2025
Q4 		$3.21K Sell
19
-20
-51% -$3.25K ﹤0.01% 608
2025
Q3 		$5.63K Hold
39
– – ﹤0.01% 563
2025
Q2 		$4.93K Buy
+39
New +$4.79K ﹤0.01% 579
2024
Q3 		– Sell
-3
Closed -$412 – 525
2024
Q2 		$412 Buy
+3
New +$400 ﹤0.01% 539
2018
Q1 		– Sell
-60
Closed -$6K – 260
2017
Q4 		$6K Hold
60
– – ﹤0.01% 225
2017
Q3 		$7K Hold
60
– – ﹤0.01% 226
2017
Q2 		$6K Hold
60
– – ﹤0.01% 247
2017
Q1 		$6K Hold
60
– – ﹤0.01% 250
2016
Q4 		$5K Hold
60
– – ﹤0.01% 250
2016
Q3 		$6K Hold
60
– – ﹤0.01% 232
2016
Q2 		$5K Hold
60
– – ﹤0.01% 233
2016
Q1 		$5K Hold
60
– – ﹤0.01% 190
2015
Q4 		$7K Hold
60
– – ﹤0.01% 200
2015
Q3 		$6K Hold
60
– – ﹤0.01% 218
2015
Q2 		$7K Buy
+60
New +$7.18K ﹤0.01% 234

Other funds holding IBB

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

American National Bank & Trust's IBB Position: Q2 2026 in Review

American National Bank & Trust sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 19 shares — an estimated $3.21K sold.

American National Bank & Trust first reported a position in IBB in Q2 2015 and held it in 16 quarters. The position peaked at $7K in Q3 2017. 310 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • American National Bank & Trust reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • American National Bank & Trust sold 19 iShares Biotechnology ETF shares in Q2 2026, an estimated $3.21K.
  • American National Bank & Trust first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 16 quarters.
  • American National Bank & Trust's iShares Biotechnology ETF position peaked at $7K in Q3 2017.
  • 310 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.